Loading clinical trials...
Loading clinical trials...
Glioblastoma (GBM) is the most common primary brain cancer in adults. Surgery, chemoradiotherapy (temozolomide TMZ) and then adjuvant TMZ is the standard treatment. But, most patients relapse in a med...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Paul Strauss
NCT05271240 · Glioblastoma, Glioblastoma Multiforme, and more
NCT05954858 · Glioma, Malignant, Glioblastoma, and more
NCT07100730 · Neoplastic Disease, Glioblastoma, and more
NCT05052957 · Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, and more
NCT06954636 · Glioblastoma Multiforme, Adult, Glioblastoma or Gliosarcoma, and more
CHRU de Nancy
Nancy, De
Centre Paul Strauss
Strasbourg
ICL
Vandœuvre-lès-Nancy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions